No takes yet. Share an insight, caveat, or question.
Randomized trial explores exosomal proteins as cancer biomarkers in tumors, suggesting innovative therapeutic strategies.
Ahmed et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: